Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...

PowerPatent provides a solution for startup founders to protect their software inventions. PowerPatent's AI Solutions for Cost-Effective Patent Filing offer an array of features that are meticulously ...

There are 18 total templates. Some of them are very unique ... A good example is a standard NDA agreement we sign with everyone to get early access or review samples. We often have to sign a ...

Acurx has now received positive written responses from the EMA (European Medicines Agency) under its Scientific Advice Procedure that the clinical, non-clinical and ...

Contrary to QXO’s assertions, Beacon offered on multiple occasions to engage, including to discuss price, subject only to a standard non-disclosure agreement (NDA). Additionally, Beacon ...

Contrary to QXO’s assertions, Beacon offered on multiple occasions to engage, including to discuss price, subject only to a standard non-disclosure agreement (NDA). Additionally, Beacon: Held repeated ...